These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
353 related items for PubMed ID: 20523039
1. Results of electrocochleography in Ménière's disease after successful vertigo control by single intratympanic gentamicin injection. Büki B, Platz M, Haslwanter T, Jünger H, Avan P. Audiol Neurootol; 2011; 16(1):49-54. PubMed ID: 20523039 [Abstract] [Full Text] [Related]
2. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease. Wu IC, Minor LB. Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316 [Abstract] [Full Text] [Related]
3. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease. Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T. Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414 [Abstract] [Full Text] [Related]
4. Intratympanic gentamicin for intractable Meniere's disease. Perez N, Martín E, García-Tapia R. Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197 [Abstract] [Full Text] [Related]
5. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss. Derebery MJ, Fisher LM, Berliner K, Chung J, Green K. Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498 [Abstract] [Full Text] [Related]
6. Summating potential and action potential ratio in Meniere's disease before and after treatment. Orchik DJ, Shea JJ, Ge NN. Am J Otol; 1998 Jul; 19(4):478-82; discussion 483. PubMed ID: 9661758 [Abstract] [Full Text] [Related]
7. Electrocochleography and gentamicin therapy for Ménière's disease: a preliminary report. Adamonis J, Stanton SG, Cashman MZ, Mattan K, Nedzelski JM, Chen JM. Am J Otol; 2000 Jul; 21(4):534-42. PubMed ID: 10912700 [Abstract] [Full Text] [Related]
18. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin. Boleas-Aguirre MS, Sánchez-Ferrandiz N, Guillén-Grima F, Perez N. Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149 [Abstract] [Full Text] [Related]
19. Intratympanic gentamicin injections for the treatment of Ménière's disease. Katzenell U, Gordon M, Page M. Otolaryngol Head Neck Surg; 2010 Nov; 143(5 Suppl 3):S24-9. PubMed ID: 20970688 [Abstract] [Full Text] [Related]
20. Outcomes in the use of intra-tympanic gentamicin in the treatment of Ménière's disease. Flanagan S, Mukherjee P, Tonkin J. J Laryngol Otol; 2006 Feb; 120(2):98-102. PubMed ID: 16359137 [Abstract] [Full Text] [Related] Page: [Next] [New Search]